
Pharmacally
SonicForce
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in SonicForce
Clinical TrialsAbbott Reports Strong TECTONIC Results for SonicForce IVLAbbott’s pivotal TECTONIC trial met both primary endpoints, reporting 97% procedural success and a 0.3% 30-day target lesion failure rate with its investigational SonicForce coronary intravascular lithotripsy system.…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.